Showing results (151-160 of 190) with videos related to
Sort By:
Pageof 19
Journal of the National Cancer Institute|January 24, 2018
Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715)Dawn L Hershman, Joseph M Unger, Katherine D Crew, et al.British Journal of Clinical Pharmacology|December 12, 2019
Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathyLauren A Marcath, Kelley M Kidwell, Kiran Vangipuram, et al.Breast Cancer Research and Treatment|April 3, 2013
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancerN Lynn Henry, Todd C Skaar, Jessica Dantzer, et al.Breast (Edinburgh, Scotland)|March 21, 2020
Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot studyTeresa M Salgado, Jin Liu, Holly L Reed, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2023
Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221Ciao-Sin Chen, Gary Zirpoli, William E Barlow, et al.JNCI Cancer Spectrum|April 2, 2025
Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trialHanna Bandos, Sungjin Kim, N Lynn Henry, et al.The Oncologist|March 25, 2016
Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast CancerKunal C Kadakia, Claire F Snyder, Kelley M Kidwell, et al.JAMA|July 13, 2018
Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical TrialDawn L Hershman, Joseph M Unger, Heather Greenlee, et al.Cancer|May 13, 2022
Cardiovascular disease risk in long-term breast cancer survivors: A population-based cohort studyAlzina Koric, Chun-Pin Chang, Bayarmaa Mark, et al.Technology in Cancer Research & Treatment|September 29, 2022
A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study ProtocolAnukriti Sharma, Ken B Johnson, Bihua Bie, et al.Pageof 19